Market news

Clorox (CLX) has put its latest acquisition to work, launching the Clorox Purell ProCare health and hygiene platform. The new platform combines CloroxPro with GOJO under a unified offering for professional and healthcare customers. For investors, the Clorox Purell ProCare launch lands at a tricky moment. The share price closed at US$83.80, with a 1-day share price return of 2.44% that sits against a 30-day share price decline of 18.27% and a 1-year total shareholder return that is down...

Clorox trades at 14x forward P/E with a 6% dividend yield but faces inflation, weak volumes, and GOJO integration risk. Click for more on CLX stock.

Clorox has raised its dividend for decades, but a cratering stock price, a payout ratio management calls elevated, and a debt load that ballooned after two major deals raise a pointed question about whether that streak survives fiscal 2027.

Clorox looks more attractive as ERP issues fade; GOJO adds growth and guidance improves. Read here for a detailed investment analysis of CLX stock.

The Clorox Company reported a 13% organic sales drop and gross margin contraction of 520 basis points, signaling ongoing operational challenges. Learn more about CLX stock here.

The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common stock. The dividend is payable November 13, 2026, to shareholders of record as of the close of business on October 28, 2026.

Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not be sustainable.

Clorox has seen its share price fall sharply over recent years, which puts fresh attention on what investors are really paying for its earnings today. With the stock back near levels that some long term holders may not have expected, the key issue is how well the current price lines up with the profits the business is generating. Over the past 5 years, Clorox shares have declined 35.4%, which raises the question of whether the market has reset expectations to match the company’s earnings...

Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Nvidia Corp (NVDA-Q) from The Globe and Mail including charting and trades.

Clorox stock is unlikely to double your money in a short time, but it can deliver excellent risk-adjusted returns over the long run.

Clorox (CLX) has drawn fresh attention after a recent move in its share price, with the stock closing at $106.69. Investors are weighing how this level aligns with the company’s fundamentals and recent returns. See our latest analysis for Clorox. The recent move to a US$106.69 share price comes after a 30 day share price return of 11.66% and a 90 day share price return of 12.18%. However, the 1 year total shareholder return has declined 7.19% and the 5 year total shareholder return has...

Clorox stock has recovered some ground in the short term, yet over the past five years shareholders have seen the share price decline about 23%, while current valuation checks still lean toward the shares looking expensive rather than like a clear bargain. Over the past five years, Clorox has delivered a share price decline of about 23%, which raises questions about how much long term value recent gains are really adding for holders. Management expects supply chain efficiencies from a new...

The Clorox Company remains a market leader but faces recent revenue and profit declines. Click here to read this latest analysis of CLX stock.

CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.

CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.

CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.

Clorox's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns. See why CLX stock is a Hold.

Church & Dwight Co., Inc. (NYSE:CHD) and The Clorox Company (NYSE:CLX) look quite different when it comes to dividends. CHD offers a much lower yield, but its dividend is growing faster. Clorox gives investors far more income today, though the company has been much more conservative with recent increases. Church & Dwight Co., Inc. (NYSE:CHD) […]

As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Clorox’s second quarter generated a positive response from investors, as revenue surpassed analyst expectations despite a 2% year-over-year decline. Management attributed the quarter’s performance to targeted improvements in product superiority, focused brand investments, and effective promotional execution in key categories. CEO Linda Rendle noted that, “the majority of our businesses are performing at or above expectations,” while acknowledging operational challenges in segments like Litter an

The household cleaning and consumer products maker expects improvements through better planning, lower inventory levels and more automation.